scholarly journals Right Lung Alveolus

2020 ◽  
Author(s):  
Keyword(s):  
2019 ◽  
Vol 5 (2) ◽  
pp. 00194-2018 ◽  
Author(s):  
Marko Z. Nikolić ◽  
Eva M. Garrido-Martin ◽  
Flavia R. Greiffo ◽  
Aurélie Fabre ◽  
Irene H. Heijink ◽  
...  

The European Respiratory Society (ERS) International Congress is the largest respiratory congress and brings together leading experts in all fields of respiratory medicine and research. ERS Assembly 3 shapes the basic and translational science aspects of this congress, aiming to combine cutting-edge novel developments in basic research with novel clinical findings. In this article, we summarise a selection of the scientific highlights from the perspective of the three groups within Assembly 3. In particular, we discuss new insights into the pathophysiology of the human alveolus, novel tools in organoid development and (epi)genome editing, as well as insights from the presented abstracts on novel therapeutic targets being identified for idiopathic pulmonary fibrosis.


2018 ◽  
Vol 23 (8) ◽  
pp. 777-789 ◽  
Author(s):  
Brian F. Niemeyer ◽  
Peng Zhao ◽  
Rubin M. Tuder ◽  
Kambez H. Benam

Lung diseases impose a significant socioeconomic burden and are a leading cause of morbidity and mortality worldwide. Moreover, respiratory medicine, unlike several other therapeutic areas, faces a disappointingly low number of new approved therapies. This is partly due to lack of reliable in vitro or in vivo models that can reproduce organ-level complexity and pathophysiological responses of human lung. Here, we examine new opportunities in application of recently emerged organ-on-chip technology to model human lung alveolus and small airway in preclinical drug development and biomarker discovery. We also discuss challenges that need to be addressed in coming years to further enhance the physiological and clinical relevance of these microsystems, enable their increased accessibility, and support their leap into personalized medicine.


Nature ◽  
2018 ◽  
Vol 555 (7695) ◽  
pp. 251-255 ◽  
Author(s):  
William J. Zacharias ◽  
David B. Frank ◽  
Jarod A. Zepp ◽  
Michael P. Morley ◽  
Farrah A. Alkhaleel ◽  
...  

2017 ◽  
Vol 103 (2) ◽  
pp. 332-340 ◽  
Author(s):  
A Jain ◽  
R Barrile ◽  
AD van der Meer ◽  
A Mammoto ◽  
T Mammoto ◽  
...  

2012 ◽  
Vol 186 (2) ◽  
pp. e2-e3 ◽  
Author(s):  
Daniel Fiole ◽  
Julien Douady ◽  
Jean-Claude Vial ◽  
Anne Quesnel-Hellmann ◽  
Jean-Nicolas Tournier

1986 ◽  
Vol 19 (7) ◽  
pp. 541-549 ◽  
Author(s):  
R. Kowe ◽  
R.C. Schroter ◽  
F.L. Matthews ◽  
D. Hitchings

2014 ◽  
Vol 8 (2) ◽  
pp. 105-111 ◽  
Author(s):  
Najla Fiaturi ◽  
John J. Castellot ◽  
Heber C. Nielsen
Keyword(s):  

1985 ◽  
Vol 249 (1) ◽  
pp. C173-C176 ◽  
Author(s):  
J. S. Torday ◽  
M. Post ◽  
B. T. Smith

The role of 11-oxidoreductase in the cellular process of fetal lung surfactant production and its localization within the alveolar domain have been investigated. In organotypic cultures of fetal rat lung, cortisol and cortisone markedly stimulate saturated phosphatidylcholine synthesis by the alveolar type II cell; a 10-fold excess of 11-ketoprogesterone blocks the bioactivity of cortisone. Both cortisol and cortisone also stimulate fibroblast-pneumonocyte factor production, whereas 11-ketoprogesterone blocks the effect of cortisone, but not of cortisol, suggesting that cortisone stimulation of fibroblast-pneumonocyte factor production depends on its conversion to cortisol by 11-oxidoreductase. A survey of the cells that are present in the alveolar domain revealed that 11-oxidoreductase activity is only present in the fibroblast. Localization of both 11-oxidoreductase and fibroblast-pneumonocyte factor production within the same cell emphasizes the significance of 11-oxidoreductase in the regulation of fetal lung surfactant production.


2011 ◽  
Vol 15 (9) ◽  
pp. 1878-1886 ◽  
Author(s):  
Wen-Jun Zhang ◽  
Qiu-Xia Lin ◽  
Ye Zhang ◽  
Chang-Ting Liu ◽  
Li-Yuan Qiu ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document